United Kingdom· GB-APID-42859911000001103
Biktarvy 30mg/120mg/15mg tablets
A emtricitabine, tenofovir alafenamide and bictegravir product containing bictegravir + emtricitabine + tenofovir alafenamide, registered in United Kingdom by Gilead Sciences Ltd. The same ATC class is registered in 13 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir alafenamide and bictegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR20 (emtricitabine, tenofovir alafenamide and bictegravir), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir alafenamide and bictegravir · ATC J05AR20
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Bictegravir + Emtricitabine + Tenofovir alafenamide
- Manufacturer
- Gilead Sciences Ltd
- Country
- United Kingdom (GB)
- ATC code
- J05AR20
- ATC class
- Emtricitabine, tenofovir alafenamide and bictegravir
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin05391507148346
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Emtricitabine, tenofovir alafenamide and bictegravir in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBiktarvyGilead Sciences, Inc.
- FinlandBiktarvyParanova Oy
- CzechiaBIKTARVYGilead Sciences Ireland UC, Carrigtohill
- SpainBIKTARVY 50 MG/200 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULAGilead Sciences Ireland Unlimited Company
- IcelandBiktarvyGilead Sciences Ireland UC*
- NorwayBiktarvyGilead Sciences Ireland UC
- SwedenBiktarvy 30 mg/120 mg/15 mg Filmdragerad tablettGilead Sciences Ireland UC
- PolandBiktarvyGilead Sciences Ireland UC
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Biktarvy
- Liechtenstein · Biktarvy
- Norway · Biktarvy
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d2f82cc9-2622-4225-8d9d-d06a6bd2c599 GET /v1/drugs/d2f82cc9-2622-4225-8d9d-d06a6bd2c599?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "42859911000001103",
"desc": "Biktarvy 30mg/120mg/15mg tablets (Gilead Sciences Ltd)",
"form": "Oral tablet",
"vpid": "42871111000001102",
"source": "dmd",
"vtm_id": "35641711000001106",
"strength": "15 mg",
"substance": "Bictegravir + Emtricitabine + Tenofovir alafenamide",
"ingredient": "Tenofovir alafenamide fumarate",
"supplier_code": "2572301000001107"
}See everything about emtricitabine, tenofovir alafenamide and bictegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.